These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17084876)

  • 1. Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression.
    Hreiche R; Mégarbane B; Pirnay S; Borron SW; Monier C; Risède P; Milan N; Descatoire V; Pessayre D; Baud FJ
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):352-62. PubMed ID: 17084876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation.
    Mégarbane B; Marie N; Pirnay S; Borron SW; Gueye PN; Risède P; Monier C; Noble F; Baud FJ
    Toxicol Appl Pharmacol; 2006 May; 212(3):256-67. PubMed ID: 16169027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of various combinations of benzodiazepines with buprenorphine on arterial blood gases in rats.
    Pirnay SO; Mégarbane B; Borron SW; Risède P; Monier C; Ricordel I; Baud FJ
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):228-39. PubMed ID: 18684226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice.
    Alhaddad H; Cisternino S; Declèves X; Tournier N; Schlatter J; Chiadmi F; Risède P; Smirnova M; Besengez C; Scherrmann JM; Baud FJ; Mégarbane B
    Crit Care Med; 2012 Dec; 40(12):3215-23. PubMed ID: 22975888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation.
    Berson A; Fau D; Fornacciari R; Degove-Goddard P; Sutton A; Descatoire V; Haouzi D; Lettéron P; Moreau A; Feldmann G; Pessayre D
    J Hepatol; 2001 Feb; 34(2):261-9. PubMed ID: 11281555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender and strain contributions to the variability of buprenorphine-related respiratory toxicity in mice.
    Alhaddad H; Cisternino S; Saubamea B; Schlatter J; Chiadmi F; Risède P; Smirnova M; Cochois-Guégan V; Tournier N; Baud FJ; Mégarbane B
    Toxicology; 2013 Mar; 305():99-108. PubMed ID: 23376546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine.
    Ohtani M; Kotaki H; Nishitateno K; Sawada Y; Iga T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):428-33. PubMed ID: 9103526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunitrazepam does not alter cerebral distribution of buprenorphine in the rat.
    Megarbane B; Pirnay S; Borron SW; Trout H; Monier C; Risède P; Boschi G; Baud FJ
    Toxicol Lett; 2005 Jul; 157(3):211-9. PubMed ID: 15917146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats.
    Cohier C; Chevillard L; Risède P; Roussel O; Mégarbane B
    Toxicol Lett; 2014 Jul; 228(2):75-84. PubMed ID: 24769261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
    Hurh E; Lee EJ; Kim YG; Kim SY; Kim SH; Kim YC; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):261-73. PubMed ID: 11913717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats.
    Yassen A; Kan J; Olofsen E; Suidgeest E; Dahan A; Danhof M
    J Pharmacol Exp Ther; 2007 May; 321(2):598-607. PubMed ID: 17283225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic doses of paraoxon alter the respiratory pattern without causing respiratory failure in rats.
    Villa AF; Houze P; Monier C; Risède P; Sarhan H; Borron SW; Mégarbane B; Garnier R; Baud FJ
    Toxicology; 2007 Mar; 232(1-2):37-49. PubMed ID: 17250945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes.
    Dey A; Yadav S; Dhawan A; Seth PK; Parmar D
    Life Sci; 2006 Sep; 79(18):1729-35. PubMed ID: 16844145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats.
    Chevillard L; Mégarbane B; Risède P; Baud FJ
    Toxicol Lett; 2009 Dec; 191(2-3):327-40. PubMed ID: 19819313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editor's Highlight: Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat.
    Cohier C; Chevillard L; Salle S; Risède P; Roussel O; Mégarbane B
    Toxicol Sci; 2017 Feb; 155(2):389-399. PubMed ID: 27803387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Apr; 56(4):477-83. PubMed ID: 15099443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid induction of hepatic acetyl CoA:arylamine N-acetyltransferase activity in the rat.
    Zaher H; Svensson CK
    Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):195-208. PubMed ID: 8202632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.